Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01829555 · ClinicalTrials.gov registry record · NA

A Pilot Study Examining a Reinforcement Approach to Improve Diabetes Management

A NA study, sponsored by UConn Health.

Completed
Registry status
NA
Development phase
10
Enrollment target

NCT01829555: Completed NA study, sponsored by UConn Health.

NCT01829555 is a NA study that has completed, run by UConn Health. The registered enrollment target is 10 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01829555, a NA study, has completed, sponsored by UConn Health.

COMPLETED
Registry status
NA
Development phase
10 participants
Enrollment target

Study Summary

Glucose control is necessary to avoid the immediate and long-term adverse effects associated with type 1 diabetes, and frequent self-monitoring of blood glucose is the first important step to achieving glucose control. Data suggest that large proportions of adolescents and young adults fail to adhere to standard guidelines of self-monitored of blood glucose testing and have hemoglobin A1c levels \>7.5%. A finite period of poor metabolic control can lead to increased risk of medical complications over an individual's lifespan, necessitating novel interventions to improve self-monitored blood glucose testing and metabolic control in emerging adults with type 1 diabetes. The investigators treatment approach, which provides direct tangible reinforcement for objective evidence of behavior change, is efficacious in decreasing substance use, reducing weight, and improving medication adherence. The purpose of this project is to develop and pilot test an intervention based on behavioral economic principles for improving self-monitored blood glucose testing in young persons with type 1 diabetes. In this pilot study, patients will text in, via cell phones, each time they test, and a return text will inform them of reinforcer vouchers earned. The investigators will collect data on self-monitored blood glucose testing frequency and A1c levels preceding treatment initiation and throughout a 6 month treatment period. If promising, a randomized trial will lead to larger scale evaluations of reinforcement interventions alone, or in combination with multimodal treatment approaches, and it may be applied to other clinical issues such as adherence to continuous glucose monitoring. Importantly, this intervention can be administered remotely and in an automated fashion, allowing for widespread adoption if efficacious.

Interventions

  • BEHAVIORAL contingency management

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2013-02
Est. Completion 2014-08
Phase NA
UConn Health

178 total trials

What the finished NCT01829555 record still lists

NCT01829555 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 1 intervention - of which contingency management is the first listed.

NCT01829555 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01829555 about?

NCT01829555 is a clinical study titled "A Pilot Study Examining a Reinforcement Approach to Improve Diabetes Management". Glucose control is necessary to avoid the immediate and long-term adverse effects associated with type 1 diabetes, and frequent self-monitoring of blood glucose is the first important step to achieving glucose control. Data suggest that large proportions of adolescents and young adults fail to adher...

What is the current status of trial NCT01829555?

This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2013-02. Estimated completion is 2014-08.

What interventions are being tested in trial NCT01829555?

The interventions under investigation include: contingency management (BEHAVIORAL).

Who is sponsoring clinical trial NCT01829555?

This trial is sponsored by UConn Health, which has 178 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01829555's enrollment target sits among peer trials

10 1927th of 2000 higher than 26 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00623389 · 10 participants · NA

    Evaluation of an Advanced Lower Extremity Neuroprostheses

  • NCT01241864 · 10 participants · Phase 2

    Islet Transplantation in Type 1 Diabetic Kidney Allograft

  • NCT01293214 · 10 participants · NA

    Vascularized Composite Allotransplantation for Multiple Extremity Amputations

  • NCT01474148 · 10 participants · NA

    A Neuroprosthesis for Seated Posture and Balance

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01829555, the US trial registry maintained by the National Library of Medicine. NCT01829555 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.